Study with us

Title

Understanding the mechanistic link between mitochondrial electron transfer and proliferation of glioblastoma multiforme cells

This project is co-sponsored by the EPSRC CDT in Chemical Biology and the CRUK Convergence Science Centre

Supervisors

• Dr Maxie Roessler, Department of Chemistry, Imperial
• Dr Kambiz Alavian, Department of Brain Sciences, Imperial
• Dr Jörg Mansfeld, Institute of Cancer Research

Abstract

Cancer cells are known to exhibit higher metabolic activity than normal cells, primarily due to their more active electron transport chain (ETC), located in the inner membrane of their mitochondria. This increased ETC activity generates a stronger proton gradient, which is counteracted by ion leakage through the inner membrane. In this project, we will explore the hypothesis that cancer cells possess a more active ETC without the corresponding ion leakage and produce less reactive oxygen species (ROS), thereby enhancing ATP production necessary for greater cell proliferation. We will focus on understanding the factors influencing ETC activity and leakage of ion channels. We will analyze (i) ETC activity in cancer cells, via respiratory complex I, using and developing innovative electron paramagnetic resonance spectroscopy techniques, (ii) metabolic efficiency via the ion leak channel located within the C subunit of the F1Fo ATP synthase, (iii) ROS production in cancer cells. By elucidating the relationship between ETC activity, oxidative phosphorylation efficiency, ATP synthesis, ROS production and cancer cell proliferation, we aim to develop novel strategies for cancer treatment and prevention.

Studentship Information and Eligibility

This studentship will form part of the 2025 entry cohort (Cohort 2) of the Institute of Chemical Biology's EPSRC Centre for Doctoral Training in Chemical Biology: Empowering UK BioTech Innovation (ICB CDT).

The project will commence in October 2025, where the successful candidates will undertake a number of ICB CDT transferrable skills training courses and training courses offered by the CRUK Convergence Science Centre alongside the research project, with their cohort, including the MRes students.

This project is only available to candidates with Home fee status. For information on what this means, please review the eligibility criteria on our website.

We will only consider candidates who have achieved an upper second or first class master's degree in a relevant subject, with at least 50% physical sciences background.

To apply for this studentship, please apply via My Imperial, and select 'Doctoral' and 'Chemistry Research (PhD).

Once your application has been submitted, please e-mail [email protected].

Application Deadline

31st January 2025

Title

Non-invasive skin patches can interrogate interstitial skin fluid to improve skin cancer diagnosis in primary care

This project is co-sponsored by the EPSRC CDT in Chemical Biology and the CRUK Convergence Science Centre

Supervisors

• Dr Sylvain Ladame, Department of Bioengineering, Imperial
• Mr Myles Smith, Institute of Cancer Research and Royal Marsden Hospital
• Professor Jessica Strid, Department of Immunology and Inflammation, Imperial

Abstract

Background

Cancers of the skin are the most common of all cancers and affect almost equally women and men. The number of cases is increasing rapidly, including for melanoma, one of the deadliest forms. Other skin cancer types such as basal cell carcinoma and cutaneous squamous cell carcinoma are thankfully less deadly but much more common. They too require fast intervention and are notoriously very hard to diagnose, especially at an early stage, without the help of a biopsy. Skin cancer diagnosis is most commonly derived from visual or digital inspection of a skin lesion by a trained professional, ideally including dermoscopy. Identification of suspicious skin lesions in primary care are typically followed by an urgent referral, leading to a skin biopsy and histopathological examination, in suspicious cases. Whilst primary care clinicians are generally accurate at recognising suspicious skin lesions (with melanoma having one of the lowest median primary care intervals), only around 15% of urgent referrals result in a malignancy diagnosis. Despite recent studies reporting on the promise of using artificial intelligence and machine learning algorithms for moderate improvement in sensitivity, this low positive predictive value results in a large number of skin biopsies performed unnecessarily every year in the UK which is distressing to the patient (long time-to-result and morbidities) and costly to the NHS which spends >£35M every year on unnecessary diagnostic procedures for skin cancer only. 

Aims

Our solution is to develop minimally invasive technologies to be used alongside visual inspection in primary care settings to provide an accurate diagnosis based on molecular biomarker signatures sampled near the suspicious lesion where their concentration is the highest.

Methods

This project will develop and exploit novel microneedle skin patches to interrogate skin fluid in a rapid and painless manner. Tested on mouse models and also on human skin biopsies sourced from dermatologists and clinical oncologists, our patches will allow us to identify and clinically validate skin cancer-specific signatures within skin fluid. More specifically, we will explore pH in interstitial skin fluid as a “universal” skin cancer biomarker.

Studentship Information and Eligibility

This studentship will form part of the 2025 entry cohort (Cohort 2) of the Institute of Chemical Biology's EPSRC Centre for Doctoral Training in Chemical Biology: Empowering UK BioTech Innovation.

The project will commence in October 2025, where the successful candidates will undertake a number of ICB CDT transferrable skills training courses and training courses offered by the CRUK Convergence Science Centre alongside the research project, with their cohort, including the MRes students.

This project is only available to candidates with Home fee status. For information on what this means, please review the eligibility criteria on our website.

We will only consider candidates who have achieved an upper second or first class master's degree in a relevant subject, with at least 50% physical sciences background.

To apply for this studentship, please apply via My Imperial, and select 'Doctoral' and 'Chemistry Research (PhD).

Once your application has been submitted, please e-mail [email protected].

Application Deadline

31st January 2025

Title

The effect of mechanical stress on radiation-induced cancer cell death investigated using molecular rotor technology

This project is co-sponsored by the EPSRC CDT in Chemical Biology and the CRUK Convergence Science Centre

Supervisors

• Professor Marina Kuimova, Department of Chemistry, Imperial
• Dr Emma Harris, Institute of Cancer Research
• Dr Graeme Birdsey, National Heart and Lung Institute, Imperial
• Dr Navita Somaiah, Institute of Cancer Research and Royal Marsden Hospital

Abstract

Stromal-dense tumours, characterised by stiff tumour microenvironments (TME), exhibit treatment resistance and aggressive behaviour in cancers such as pancreatic and breast. While considerable research focuses on relieving intratumoural pressure for the purpose of improved drug delivery, little attention has been given to the role of mechanical stress on cellular responses to radiation. Emerging evidence suggests mechanical stress, such as extracellular matrix (ECM)-induced compressive stress, influences cancer cells' radiosensitivity through mechanoreceptors and mechanotransducers. Further in vitro evidence supports enhancement of cancer cell radiosensitivity after shear stress applied using ultrasound stimulated microbubbles. This project proposes novel technologies to monitor, for the first time,  the effects of mechanical stress, combined with radiation therapy, on cell membranes. It aims to explore the relationship between compressive TME and transient shear forces and cellular responses to radiation, hypothesising that mechanical stress is a key modulator of radiation-induced cancer cell death. This research will deliver novel insights into optimising treatment strategies for mechanically stressed tumours.

Studentship Information and Eligibility

This studentship will form part of the 2025 entry cohort (Cohort 2) of the Institute of Chemical Biology's EPSRC Centre for Doctoral Training in Chemical Biology: Empowering UK BioTech Innovation.

The project will commence in October 2025, where the successful candidates will undertake a number of ICB CDT transferrable skills training courses and training courses offered by the CRUK Convergence Science Centre alongside the research project, with their cohort, including the MRes students.

This project is only available to candidates with Home fee status. For information on what this means, please review the eligibility criteria on our website.

We will only consider candidates who have achieved an upper second or first class master's degree in a relevant subject, with at least 50% physical sciences background.

To apply for this studentship, please apply via My Imperial, and select 'Doctoral' and 'Chemistry Research (PhD).

Once your application has been submitted, please e-mail [email protected].

Application Deadline

31st January 2025